Xencor (XNCR) Current Deferred Revenue (2013 - 2024)

Xencor's (XNCR) quarterly Current Deferred Revenue came in at $36.5 million in Q2 2024, up 361.67% year-on-year from $7.9 million in Q3 2023, and up 6.99% on a QoQ basis from $34.1 million in Q1 2024.

Xencor (XNCR) Current Deferred Revenue (2013 - 2024) Analysis & Trends

Xencor (XNCR) has 12 years of Current Deferred Revenue data on file, last reported at $36.5 million in Q2 2024.

  • On a quarterly basis, Current Deferred Revenue rose 361.67% year-over-year to $36.5 million in Q2 2024; TTM through Jun 2024 was $36.5 million, a 361.67% increase from a year earlier, with the FY2022 full-year figure at $30.3 million, down 18.71% from the prior year.
  • Current Deferred Revenue for Q2 2024 stood at $36.5 million, up from $34.1 million in the prior quarter.
  • Over the last five years, Current Deferred Revenue for XNCR reached as high as $92.6 million in Q4 2020 and fell as low as $7.9 million in Q2 2023.
  • Historically, Current Deferred Revenue has averaged $37.0 million across 5 years, with a median of $35.3 million in 2022.
  • Across the five-year window, Current Deferred Revenue tumbled 77.62% in 2023 and soared 361.67% in 2024, its largest moves.
  • Year by year, Current Deferred Revenue stood at $92.6 million in 2020, then slumped by 59.72% to $37.3 million in 2021, then retreated by 18.71% to $30.3 million in 2022, then tumbled by 69.58% to $9.2 million in 2023, then jumped by 295.49% to $36.5 million in 2024.
  • Per Business Quant data, the three most recent Current Deferred Revenue figures were $36.5 million in Q2 2024, $34.1 million in Q1 2024, and $9.2 million in Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Xencor 1.47 Bn 1.09 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2024 36.47 Mn
Mar 31, 2024 34.09 Mn
Sep 30, 2023 9.22 Mn
Jun 30, 2023 7.90 Mn
Mar 31, 2023 30.10 Mn
Dec 31, 2022 30.32 Mn
Sep 30, 2022 35.20 Mn
Jun 30, 2022 35.30 Mn
Mar 31, 2022 35.50 Mn
Dec 31, 2021 37.30 Mn
Sep 30, 2021 13.00 Mn
Jun 30, 2021 19.20 Mn
Mar 31, 2021 77.80 Mn
Dec 31, 2020 92.60 Mn
Sep 30, 2020 43.80 Mn
Jun 30, 2020 44.70 Mn
Mar 31, 2020 46.20 Mn
Dec 31, 2019 45.21 Mn
Sep 30, 2019 48.20 Mn
Jun 30, 2019 45.50 Mn